Andrew Scanga

2.4k citations
19 papers · 683 indexed · h-index 10
Topics
Liver Disease Diagnosis and Treatment (10 papers)Liver Disease and Transplantation (9 papers)Hepatocellular Carcinoma Treatment and Prognosis (7 papers)

In The Last Decade

Andrew Scanga

18 papers receiving 676 citations

Peers

Andrew Scanga
Comparison fields: 5 of 75
  • Hepatology 383
  • Epidemiology 295
  • Surgery 175
  • Molecular Biology 156
  • Pulmonary and Respiratory Medicine 65
Replace Aysha Ali with:
Aysha Ali United Kingdom
Vikas Sud United States
Sukhwinderjit Lidder United Kingdom
Motonobu Watanabe Japan
Shigenari Hozawa Japan
Kei Furui Japan
Carolina Jiménez Calvente United States
Akira Sakamaki Japan
Joana Rita Carvalho Portugal
Stefan A. Topp Germany
Andrew Scanga relative to Aysha Ali United Kingdom Aysha Ali's profile →
Citations per field
00.5×1.5×
Aysha Ali · 1×
Citations per year

Countries citing papers authored by Andrew Scanga

Since Specialization
Citations

This map shows the geographic impact of Andrew Scanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Scanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Scanga more than expected).

Fields of papers citing papers by Andrew Scanga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Scanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Scanga. The network helps show where Andrew Scanga may publish in the future.

Co-authorship network of co-authors of Andrew Scanga

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Scanga. A scholar is included among the top collaborators of Andrew Scanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Scanga. Andrew Scanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 2
2 3
3 1
4 28
5 4
6 18
7 44
8 0
9 84
10 14
11 2
12 2
13 14
14 25
15 3
16 33
17 251
18 154
19 1

About Andrew Scanga

Andrew Scanga is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 19 papers that have together received 683 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). The work is most often cited by research in Hepatology (383 citations), Epidemiology (295 citations) and Immunology and Allergy (30 citations). Andrew Scanga has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Shimon Reif, Richard A. Rippe, Yutaka Yata, David A. Brenner, Alon Lang, Erwin Gäbele, Liu Yang, Michael Breindl, Kris V. Kowdley and Julia Wattacheril. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026